---
schema_version: "secwatch.filing_event.v1"
accession: "0001799191-23-000040"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2023-08-30T23:59:59+00:00"
generated_at: "2026-06-11T02:03:18.721303+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oncology Institute authorizes up to 2M share repurchase at ≤$1.00; Deerfield consents

## Summary
- Board approved repurchase of up to 2M shares of common stock at price not exceeding $1.00 per share.
- Limited Consent with Deerfield permits repurchases on or before Sep 16, 2023 under same price cap.
- Repurchased shares will be returned to authorized but unissued status.
- Company not obligated to repurchase any shares; timing subject to market conditions.
- Limited Consent also grants one-time waiver of certain notice requirements under Facility Agreement.

## SEC filing metadata
- accession: 0001799191-23-000040
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2023-08-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000040/0001799191-23-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000179919123000040/toi-20230830.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001799191-23-000040
- JSON: https://secwatch.observer/filing/0001799191-23-000040.json
- Plain text: https://secwatch.observer/filing/0001799191-23-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.